MedPath

扬子江药业集团北京海燕药业有限公司

Ownership
-
Established
2004-02-23
Employees
-
Market Cap
-
Website
www.bjhaiyan.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

9

NMPA:9

Drug Approvals

Celecoxib Capsules

Product Name
塞来昔布胶囊
Approval Number
国药准字H20213586
Approval Date
Jul 20, 2021
NMPA

Racecadotril Tablets

Product Name
莫尼卡
Approval Number
国药准字H20052604
Approval Date
Dec 11, 2020
NMPA

Racecadotril Tablets

Product Name
莫尼卡
Approval Number
国药准字H20052603
Approval Date
Dec 7, 2020
NMPA

苏黄止咳胶囊

Approval Number
国药准字Z20103075
Approval Date
Nov 17, 2020
NMPA

Memantine Hydrochloride Tablets

Product Name
盐酸美金刚片
Approval Number
国药准字H20203349
Approval Date
Jul 21, 2020
NMPA

Rizatriptan Benzoate Tablets

Product Name
苯甲酸利扎曲普坦片
Approval Number
国药准字H20130098
Approval Date
Oct 23, 2018
NMPA

Tiopronin for Injection

Product Name
注射用硫普罗宁
Approval Number
国药准字H20063162
Approval Date
Jan 10, 2006
NMPA

Nicardipine Hydrochloride Injection

Product Name
盐酸尼卡地平注射液
Approval Number
国药准字H20052608
Approval Date
Dec 23, 2005
NMPA

Nicardipine Hydrochloride Injection

Product Name
盐酸尼卡地平注射液
Approval Number
国药准字H20052609
Approval Date
Dec 23, 2005
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.